Is GoodRx Holdings, Inc. (GDRX) a Buy, Sell, or Hold?
NASDAQ : GDRX
GoodRx Holdings, Inc.
$3.14 USD
$0.02 (0.64%)
- Volume
- 1.52M
- Average Volume
- 1.45M
- Market Capitalization
- $1.09B
- P/E Ratio
- 53.58
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $5.81
- Year Low
- $1.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.47
Analyst Consensus Summary
Consensus Rating
Neutral
24 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
4.7%
vs Current Price
Price Target
$3.00
Average TargetPrice Target Range
Lowest Target
$2.75
14.2% UPSIDE
Average Target
$3.00
Median Estimate
Highest Target
$3.50
-10.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 24
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 10 | 13 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Goldman Sachs | Eric Sheridan | $3.5 | $2.84 | 2026-05-08 07:57 AM | 23.2% |
| Leerink Partners | Michael Cherny | $3 | $2.0241 | 2026-02-26 01:08 PM | 48.2% |
| Jefferies | Glen Santangelo | $2.75 | $2.58 | 2026-01-22 01:00 AM | 6.6% |
| Deutsche Bank | George Hill | $6 | $3.47 | 2025-08-11 07:01 AM | 72.9% |
| Morgan Stanley | Craig Hettenbach | $9.5 | $8.55 | 2024-06-10 01:32 AM | 11.1% |
| RBC Capital | Mark Mahaney | $10 | $7.2 | 2024-05-22 09:50 PM | 38.9% |
| Barclays | Stephanie Davis | $9 | $8.06 | 2024-05-16 10:46 AM | 11.7% |
| Raymond James | Aaron Kessler | $10 | $7.27 | 2024-05-16 01:57 AM | 37.6% |